Skip to content

Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Culturally Adapted Transdiagnostic Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03496350
Enrollment
59
Registered
2018-04-12
Start date
2019-01-07
Completion date
2019-12-01
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Brief summary

The purpose of this study is to evaluate the efficacy of a culturally adapted internet-administrated cognitive behaviour therapy (ICBT) in Arabic for anxiety and depression

Detailed description

The study will compare the effect of the intervention against a wait-list control. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Arabic.

Interventions

Culturally adapted transdiagnostic internet-delivered CBT in Arabic

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants get randomly assigned to either treatment or wait-list control.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Be above 18 years of age * Have symptoms of anxiety and/or depression * Be able to read and write in Arabic * Have access to computer or smartphone

Exclusion criteria

* Suicidal ideation * Alcohol addiction * Other major primary psychiatric disorder * Ongoing psychological treatment * Recent (during last 4 weeks) change in psychiatric medication

Design outcomes

Primary

MeasureTime frameDescription
Change in Patient Health Questionnaire (PHQ-9)pre-treatment ,week 3, week 6, week 8 and 12 months post-treatmentThe PHQ-9 is a nine-item self-report questionnaire that measures symptoms of depression. It is scored from 0-27 with a higher score reflecting more severe symptoms.
Change in Generalised Anxiety Disorder-7-item scale, (GAD-7)pre-treatment ,week 3, week 6, week 8 and 12 months post-treatmentThe GAD-7 is a seven-item self-report questionnaire that measures symptoms of anxiety. It is scored from 0-21 with a higher score reflecting more severe symptoms.

Secondary

MeasureTime frameDescription
Impact of Events Scale - Revised (IES-R)pre-treatment, week 8Self-reported symptoms of post-traumatic stress. It is scored from 0-88 where higher scores reflect more symptoms.
Alcohol Use Disorder Identification Test (AUDIT)pre-treatment, week 8Measures alcohol consumption, drinking behaviors, and alcohol-related problems. It is scored from 0-40 with higher scores reflecting more alcohol consumption, drinking behaviors, and alcohol-related problems.
Brunnsviken Brief Quality of Life Scale (BBQ)pre-treatment, week 8Self-reported quality of life. The scale is scored from 0-96 with a higher score reflecting higher self-reported quality of life.
Perceived Stress Scale (PSS)pre-treatment, week 8Self-reported stress-related symptoms. It is scored from 0-56 with higher scores reflecting more symtoms of perceived stress.
Insomnia Severity Index (ISI)pre-treatment, week 8Self-reported symptoms of insomnia. It is scored from 0-28 with higher scores reflecting more symptoms of insomnia.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026